{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicac6kkw2duhxuvzi6lr5hjdwxjtq6hlbf2of4joodzqo57iw65s4",
    "uri": "at://did:plc:oznbnvgr7dmvddiyvr7dih52/app.bsky.feed.post/3mf7xy6ccvki2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicn2y2vwypekcfyhkwjylswzaceupewgiovjw5klmx222qept6bpi"
    },
    "mimeType": "image/jpeg",
    "size": 33975
  },
  "path": "/health/dementia-supplement-memory",
  "publishedAt": "2026-02-19T15:31:24.000Z",
  "site": "https://www.gbnews.com",
  "tags": [
    "analysis",
    "Cancer warning: 'The symptoms I ignored when I was 20 turned out to be a brain tumour'",
    "Weight loss: Scientists discover smarter way to time calorie intake to shed extra pounds",
    "Black tea could dampen 'silent inflammation' linked to type 2 diabetes - how much you need",
    "The GB News Editorial Charter"
  ],
  "textContent": "\n\n\nGinkgo biloba supplements may deliver negligible benefits for individuals experiencing mild cognitive impairment, according to a new review.\n\nThe analysis, published in the Cochrane Database of Systematic Reviews, examined the popular herbal supplement's effectiveness across various cognitive conditions.\n\n###\n\n\n\n\nResearchers found those with mild cognitive impairment or multiple sclerosis-related cognitive difficulties showed no meaningful improvement when taking ginkgo compared with a placebo.\n\nHowever, the picture differs somewhat for patients already living with a dementia diagnosis.\n\n###\n\n\n\n\nTRENDING\n\nStories\n\nVideos\n\nYour Say\n\n###\n\n\n\n\nFor this group, the review identified small to moderate improvements in overall clinical status, cognitive function, and daily task performance.\n\nThese potential symptomatic benefits remain modest rather than transformative.\n\nThe review's scope was substantial, drawing upon 82 randomised controlled trials encompassing 10,613 participants.\n\nOf these studies, 72 provided data suitable for extraction, although not all outcomes could be pooled quantitatively.\n\n###\n\n\n\n\n###\n\n\n\n\nParticipants included individuals with subjective memory complaints, multiple sclerosis, mild cognitive impairment, and diagnosed dementia, such as Alzheimer's or vascular dementia.\n\nCrucially, the evidence supporting ginkgo's benefits for dementia patients carries low certainty, as results have varied considerably across different trials.\n\nFurthermore, longer-term data extending beyond approximately six months remained limited and current findings demonstrate only possible symptomatic relief rather than any disease-modifying effects.\n\nDementia represents a spectrum of progressive neurocognitive disorders marked by substantial deterioration in memory, thinking and behaviour that frequently disrupts everyday life.\n\n### LATEST DEVELOPMENTS\n\n\n\n\n  * Cancer warning: 'The symptoms I ignored when I was 20 turned out to be a brain tumour'\n  * Weight loss: Scientists discover smarter way to time calorie intake to shed extra pounds\n  * Black tea could dampen 'silent inflammation' linked to type 2 diabetes - how much you need\n\n\n\n###\n\n\n\n\nThe condition is increasingly viewed as a global health emergency, with projections suggesting 1.4 billion people will be aged 60 and above by 2030.\n\nDespite decades of investigation, neither dementia nor Alzheimer's disease has a scientifically proven cure or established disease-modifying treatment.\n\nCurrent approaches focus on preventing onset through risk assessment and slowing progression following diagnosis.\n\nThis therapeutic vacuum drives many towards alternative remedies found in traditional medicine and widely promoted supplements.\n\n###\n\n\n\n\n###\n\n\n\n\nGinkgo biloba, derived from one of the planet's oldest surviving tree species, ranks among the most sought-after options.\n\nThe review's authors are unequivocal in their clinical interpretation that ginkgo cannot be considered a preventive remedy for cognitive decline in healthy or mildly impaired individuals.\n\n###\n\n\n\n\n###\n\n\n\n\nFor those already diagnosed with dementia, any benefits appear limited to modest symptomatic improvement rather than halting disease progression.\n\nSubstantial variation across the randomised trials underscores the pressing need for standardised research methodologies.\n\nLonger-term studies are also required to determine which patient groups, whether those with Alzheimer's or vascular dementia, might derive the greatest advantage from supplementation.\n\nUntil such evidence emerges, ginkgo remains far from the cognitive panacea many consumers hope to find.\n\n**Our Standards:The GB News Editorial Charter **",
  "title": "Brain supplement may offer benefits to dementia patients but not healthy adults, study finds"
}